Sagittarius Life Science Corp (TPEX:3205)
Taiwan · Delayed Price · Currency is TWD 48.20
+0.60 (1.26%)
Jul 30, 2026, 9:42 AM CST
Sagittarius Life Science Market Cap
Sagittarius Life Science has a market cap or net worth of 3.22 billion as of July 29, 2026. Its market cap has increased by 110.64% in one year.
Market Cap
3.22B
Enterprise Value
3.08B
Revenue
392.26M
Ranking
n/a
PE Ratio
n/a
Stock Price
48.20
ChartMarket Cap Chart
Since May 2, 2006, Sagittarius Life Science's market cap has increased from 288.69M to 3.22B, an increase of 1,013.72%. That is a compound annual growth rate of 12.64%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 30, 2026 | 3.22B | -7.21% |
| Dec 31, 2025 | 3.47B | 233.24% |
| Dec 31, 2024 | 1.04B | -38.79% |
| Dec 29, 2023 | 1.70B | 28.26% |
| Dec 30, 2022 | 1.32B | 48.00% |
| Dec 30, 2021 | 895.00M | -19.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Formosa Pharmaceuticals | 3.67B |
| Genovate Biotechnology | 3.65B |
| Senhwa Biosciences | 3.52B |
| OBI Pharma | 3.46B |
| BioGend Therapeutics | 3.27B |
| Great Novel Therapeutics Biotech & Medicals | 3.23B |
| SYN-TECH Chem. & Pharm. | 3.20B |
| Apex Biotechnology | 3.17B |